Functional distinction of rat liver natural killer cells from spleen natural killer cells under normal and acidic conditions in vitro

Hepatobiliary and Pancreatic Diseases International

Volumn 11, Issue 3, 2012, Pages 285-293

  Lv, Li Hong ^a   Yu, Jian Dong ^a   Li, Guo Lin ^a   Long, Tian Zhu ^b   Zhang, Wei ^c   Chen, Ya Jin ^a   Min, Jun ^a   Wan, Yun Le ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangzhou Women and Children's Medical Center   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Extracellular pH; Liver; Natural killer cells; Spleen; Tumor microenvironment

Indexed keywords

GAMMA INTERFERON; LACTATE DEHYDROGENASE;

ACIDITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL MEDIATED CYTOTOXICITY; CELL PH; CELL SIZE; CELL STRUCTURE; CONTROLLED STUDY; IN VITRO STUDY; INTERFERON PRODUCTION; LIVER CELL; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; RAT; SPLEEN CELL; TUMOR MICROENVIRONMENT;

EID: 84861994022     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(12)60162-3     Document Type: Article

References (30)

1. Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol 2001;1:41-49.
2. Moretta L, Ferlazzo G, Bottino C, Vitale M, Pende D, Mingari MC, et al. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 2006;214:219-228.
3. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376.
4. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology 2006;43:S54-62.
5. Gao B, Jeong WI, Tian Z. Liver: An organ with predominant innate immunity. Hepatology 2008;47:729-736.
6. Vanderkerken K, Bouwens L, Wisse E. Characterization of a phenotypically and functionally distinct subset of large granular lymphocytes (pit cells) in rat liver sinusoids. Hepatology 1990;12:70-75.
7. Wisse E, Luo D, Vermijlen D, Kanellopoulou C, De Zanger R, Braet F. On the function of pit cells, the liver-specific natural killer cells. Semin Liver Dis 1997;17:265-286.
8. Wisse E, van't Noordende JM, van der Meulen J, Daems WT. The pit cell: description of a new type of cell occurring in rat liver sinusoids and peripheral blood. Cell Tissue Res 1976;173:423-435.
9. Lotzová E. Definition and functions of natural killer cells. Nat Immun 1993;12:169-176.
10. Vermijlen D, Luo D, Froelich CJ, Medema JP, Kummer JA, Willems E, et al. Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway. J Leukoc Biol 2002;72:668-676.
11. Ishiyama K, Ohdan H, Ohira M, Mitsuta H, Arihiro K, Asahara T. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans. Hepatology 2006;43:362-372.
12. Vujanovic NL, Polimeno L, Azzarone A, Francavilla A, Chambers WH, Starzl TE, et al. Changes of liver-resident NK cells during liver regeneration in rats. J Immunol 1995;154: 6324-6338.
13. Hata K, Van Thiel DH, Herberman RB, Whiteside TL. Natural killer activity of human liver-derived lymphocytes in various liver diseases. Hepatology 1991;14:495-503.
14. Winnock M, Garcia-Barcina M, Huet S, Bernard P, Saric J, Bioulac-Sage P, et al. Functional characterization of liverassociated lymphocytes in patients with liver metastasis. Gastroenterology 1993;105:1152-1158.
15. Wike-Hooley JL, Haveman J, Reinhold HS. The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol 1984;2:343-366.
16. Rotin D, Robinson B, Tannock IF. Influence of hypoxia and an acidic environment on the metabolism and viability of cultured cells: potential implications for cell death in tumors. Cancer Res 1986;46:2821-2826.
17. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989;49:6449-6465.
18. Martin GR, Jain RK. Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy. Cancer Res 1994;54:5670-5674.
19. Helmlinger G, Yuan F, Dellian M, Jain RK. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 1997;3: 177-182.
20. Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 1998;58:1408-1416.
21. Gerweck LE, Seetharaman K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res 1996;56:1194-1198.
22. Lardner A. The effects of extracellular pH on immune function. J Leukoc Biol 2001;69:522-530.
23. Severin T, Müller B, Giese G, Uhl B, Wolf B, Hauschildt S, et al. pH-dependent LAK cell cytotoxicity. Tumour Biol 1994; 15:304-310.
24. Loeffler DA, Juneau PL, Heppner GH. Natural killercell activity under conditions reflective of tumor microenvironment. Int J Cancer 1991;48:895-899.
25. Loeffler DA, Juneau PL, Masserant S. Influence of tumour physico-chemical conditions on interleukin-2-stimulated lymphocyte proliferation. Br J Cancer 1992;66:619-622.
26. 2+ and pH. J Immunol 1991;147:3638-3645.
27. Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990;76:2421-2438.
28. Whittington R, Faulds D. Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer. Drugs 1993;46:446-514.
29. Thistlethwaite AJ, Leeper DB, Moylan DJ 3rd, Nerlinger RE. pH distribution in human tumors. Int J Radiat Oncol Biol Phys 1985;11:1647-1652.
30. Smyth MJ, Hayakawa Y, Takeda K, Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2002;2:850-861.